About this trial
The goal of this observational study is to evaluate whether a new integrated mathematical model can improve the accuracy of diagnosing septic cardiomyopathy and predicting clinical outcomes in adult patients with suspected septic cardiomyopathy. The study aims to determine whether the integrated mathematical model enhances diagnostic accuracy and improves the prediction of clinical outcomes in these patients.
Eligibility criteria
Qualifiers
Age 18 years or older;
Suspected/confirmed infection and
SOFA (Sequential Organ Failure Assessment) score ≥ 2 or qSOFA score ≥ 2;
Sepsis is diagnosed and
Disqualifiers
Individuals under 18 years of age;
Cardiogenic shock;
Congenital heart disease;
Heart failure NYHA functional class IV;
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Vilnius University
Lead sponsor
Vilnius University Hospital Santaros Klinikos
Collaborator